BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Halyard Health to Webcast Conference Call Discussing Fourth Quarter and Full-Year 2017 Financial Results

  Halyard Health will webcast a conference call discussing its financial results and business highlights for the fourth quarter and full-year 2017, and its 2018 outlook, on Tuesday, Feb. 27 at 9 a.m. ET.

  February 13, 2018

   · 

  1 min read
• BioForest

  CTI BioPharma Announces Closing of Underwritten Public Offering of Common Stock

  The expected proceeds to CTI BioPharma from the offering are approximately $64.2M.

  February 13, 2018

   · 

  5 min read
• Pharm Country

  Newron Supports Global Rare Disease Day 2018 and Rett Syndrome Studies

  Observed on February 28, Rare Disease Day helps raise awareness of rare diseases, and in turn improve access to treatments.

  February 13, 2018

   · 

  8 min read
• Genetown

  CureVac to Pursue Innovative mRNA Vaccines Against Flu and Malaria

  CureVac today announced the awarding of two new grants from the Bill & Melinda Gates Foundation.

  February 13, 2018

   · 

  4 min read
• Business

  Charles River Laboratories Announces Executive Management Appointments

  Dr. Davide Molho will become President and Chief Operating Officer of Charles River, effective immediately, and will add Discovery Services to his responsibilities.

  February 13, 2018

   · 

  6 min read
• Business

  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2017 Results from Continuing Operations and Provides 2018 Guidance

  For the quarter, revenue from continuing operations was $478.5 million, an increase of 2.5% from $466.8 million in the fourth quarter of 2016.

  February 13, 2018

   · 

  33 min read
• Pharm Country

  Citius Publishes Expert Roundtable Discussion on Treatment Considerations for Catheter Related Bacteremias

  The experts participating in the roundtable included Infectious Disease specialists.

  February 13, 2018

   · 

  5 min read
• Drug Development

  Sangamo Presents Oncology Genome Editing Capabilities at Keystone Symposium on Emerging Cellular Therapies

  Sangamo yesterday presented preclinical data demonstrating the Company’s engineering capabilities in T cell genome editing using zinc finger nucleases.

  February 13, 2018

   · 

  6 min read
• Business

  Arcturus Therapeutics Appoints Dr. Christine Esau as Vice President of Research and Development

  Concurrently, Dr. Pad Chivukula is stepping down as Chief Scientific Officer and Chief Operating Officer and will serve as a Scientific Advisor to the Company.

  February 13, 2018

   · 

  5 min read
• Business

  Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018

  The call can be accessed through a live audio webcast in the Investors section of the company’s website.

  February 13, 2018

   · 

  1 min read